Here, we extended the earlier report from the breast cancer cohort treated at Odense University Hospital; measured a panel of seven IGF‐related circulating biomarkers; performed prognostic modeling against long‐term survival; and then evaluated performance characteristics against the clinically used prognostic model, namely the Nottingham Prognostic Index (NPI). This evidence concerns the gene IGF1 and breast cancer.